QLT, Inc. (NASDAQ: QLTI), a global biopharmaceutical company, has dedicated their efforts to discovering, developing and commercializing novel therapies. The company’s research and development efforts are focused on the field of ophthalmology. QLT leverages its three unique technology platforms, photodynamic therapy, Atrigel® and punctal plugs with drugs, to develop products such as Visudyne® and Eligard® and future product opportunities. For further information, visit the Company’s web site at www.qltinc.com.
QLT, Inc. (NASDAQ: QLTI)
November 3, 2008 at 5:09am
Archives
Select A Month
